December 2024 in “Journal of Clinical Medicine” This study reported that both 5% topical and oral minoxidil achieved an 82% hair regrowth response rate in alopecia areata patients, but 5% topical minoxidil was more effective than lower concentrations.
3 citations
,
July 2023 in “International journal of molecular sciences” This review discusses the association between emotional stress-related neuropeptides and the pathogenesis of alopecia areata, reporting no new experimental findings.
June 2023 in “Annals of the College of Medecine” This study found that childbearing women with telogen effluvium had significantly lower ferritin levels compared to healthy controls, and observed a strong inverse correlation between ferritin levels and the amount of hair shed, suggesting low iron stores may contribute to hair loss.
29 citations
,
January 2023 in “Journal of Clinical Medicine” This review discusses psychological treatments for alopecia, finding limited but positive effects on mental health, quality of life, and possibly hair growth; however, more research is needed to establish intervention efficacy.
18 citations
,
November 2021 in “Skin Appendage Disorders” This study found that women with nonscarring alopecia had lower ferritin levels compared to women without the condition.
March 2020 in “QJM: An International Journal of Medicine” This study found that intradermal minoxidil 5% alone and with intralesional triamcinolone acetonide significantly reduced alopecia areata dermoscopic findings, while standard intralesional corticosteroids remain the main first-line treatment for patchy alopecia with less than 50% scalp involvement.